Bias, Spin, and Misreporting: Time for Full Access to Trial Protocols and Results
Open Access
- 25 November 2008
- journal article
- perspective
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 5 (11) , e230
- https://doi.org/10.1371/journal.pmed.0050230
Abstract
An-Wen Chan discusses the implications of a new study inPLoS Medicine that suggests that the randomized trial literature is skewed towards reporting favorable results.Keywords
This publication has 33 references indexed in Scilit:
- Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and PresentationPLoS Medicine, 2008
- Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health ResearchCMAJ : Canadian Medical Association Journal, 2004
- Empirical Evidence for Selective Reporting of Outcomes in Randomized TrialsJAMA, 2004
- Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished dataThe Lancet, 2004
- Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology GroupBMJ, 2004
- Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applicationsBMJ, 2003
- The power of the protocolThe Lancet, 2002
- Investigation of within‐study selective reporting in clinical research: follow‐up of applications submitted to a local research ethics committeeJournal of Evaluation in Clinical Practice, 2002
- Publication and related biases.Health Technology Assessment, 2000
- Study of information submitted by drug companies to licensing authorities.BMJ, 1980